NCT06408207
CGM Academy for Youth With Type 1 Diabetes
Recruiting
NAAges 8–18InterventionalTreatmentChildren's Hospital Los AngelesInvestigator-initiated
~90 participants
Updated 2026-02-06 on ClinicalTrials.gov
What's tested:CGM Academy
At a glance
Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Mean change in Hemoglobin A1c from baseline to 6 months
Measured over Baseline to 6 months
Conditions
Where it's being run
1 sites across 1 statesCalifornia1
Study leadership
- Rebecca Barber, PhD, RN · PRINCIPAL_INVESTIGATOR · Children's Hospital Los Angeles
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Current age of 8-18 years, age group eligible for CGM therapy with Dexcom G6 and G7
T1D duration ≥6 months, as insulin adjustments during honeymoon stage differs from establishedT1D
Able to speak, read, and write English or Spanish
Smartphone compatible with Dexcom G6 and G7application
Ability to participate in virtual visits
What this trial measures
- Mean change in Hemoglobin A1c from baseline to 6 monthsBaseline to 6 months
Change in Hemoglobin A1c